Li-Ming Su
M.D./Professor/Chair
- Gainesville FL UNITED STATES
- College of Medicine
Dr. Li-Ming Su specializes in minimally invasive surgery for prostate and kidney cancer.
Contact More Open optionsBiography
Dr. Li-Ming Su serves as the Pete and Carolyn Newsome Professor of Urologic Oncology and chair of the Department of Urology in the College of Medicine. He specializes in minimally invasive surgery for prostate and kidney cancer. Dr. Su works with the da Vinci Robotic Surgical System to perform robotic nerve-sparing radical prostatectomy and robotic partial nephrectomy. His other interests include pyeloplasty for renal obstruction and adrenalectomy for hormone-producing adrenal tumors. His research interest involve advanced imaging for prostate and kidney tumors.
Areas of Expertise
Media Appearances
UF Health hosts 'Prostate Cancer Awareness Month' event
WCJB tv
2018-09-04
September is Prostate Cancer Awareness month and today UF Health held an event to show the public the latest treatment options for the disease. The event shared new prostate screening recommendations such as men getting a prostate specific antigen blood test before prostate examinations.
Using Lasers to Diagnose Cancerous Kidney Tumors
WUFT tv
2016-04-07
University of Florida Health researchers, Dr. Li-Ming Su and Dr. Robert Allan are working to determine whether a tiny laser imaging probe can help detect whether a kidney tumor is cancerous or benign prior to subjecting a patient to an invasive needle biopsy or surgery.
Social
Articles
Perioperative Aspirin Use Is Associated with Bleeding Complications during Robotic Partial Nephrectomy
The Journal of UrologyLi-Ming Su, et al.
2022-02-01
Daily aspirin use following cardiovascular intervention is commonplace and creates concern regarding bleeding risk in patients undergoing surgery. Despite its cardio-protective role, aspirin is often discontinued 5–7 days prior to major surgery due to bleeding concerns. Single institution studies have investigated perioperative outcomes of aspirin use in robotic partial nephrectomy (RPN). Researchers sought to evaluate the outcomes of perioperative aspirin (pASA) use during RPN in a multicenter setting.
Robot-Assisted Radical Nephroureterectomy
Journal of EndourologyLi-Ming Su, et al.
2021-09-09
First proposed by Kimball and Ferris in 1933 for the treatment of papillary tumors in the upper urinary tract, radical nephroureterectomy (RNU) with bladder cuff excision remains the gold standard for management of high-risk upper tract urothelial carcinoma involving the proximal ureter and/or pelvicaliceal system. Minimally invasive approaches to RNU have continued to evolve and become increasingly utilized. More recently, robot-assisted RNU (RARNU) has increasingly become a viable approach.
Association between nuclear grade of renal cell carcinoma and the aorta-lesion-attenuation-difference
Kidneys, Ureters, Bladder, RetroperitoneumLi-Ming Su, et al.
2021-08-31
Several features noted on renal mass biopsy (RMB) can influence treatment selection including tumor histology and nuclear grade. However, there is poor concordance between renal cell carcinoma (RCC) nuclear grade on RMB compared to nephrectomy specimens. Here, we evaluate the association of nuclear grade with aorta-lesion-attenuation-difference (ALAD) values determined on preoperative CT scan.
